Ole Falvig Ramsby

Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland.

Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden.

bioMASON, Inc. operates as a biotechnology manufacturing company that serves the building and construction industry. It offers concrete, glass, steel, and wood. The company was founded by Ginger Krieg Dosier in 2012 and is headquartered in Research Triangle Park, NC.

Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom.

Part of FLSmidth & Co. A/S, FLSmidth A/S is a Danish company that provides flowsheet technology services. The company is based in Valby, Denmark. The company was founded in 1991 by Ole Falvig Ramsby, Birger Riisager. The CEO is Mikko Juhani Keto.

NNE Pharmaplan A/S produces pharmaceutical products. The company is based in Soborg, Denmark.